Genomtec has secured an additional distributor for its Gentomec®ID portable testing platform and RP5-PLEX panel for detecting respiratory tract infections in Europe by entering into an agreement with ForLab SA. Forlab is the second distributor of the Company’s flagship platform after the Greek company Atropos. ForLab has become Genomtec’s exclusive sales partner in Belgium, the Netherlands and Luxembourg. The company has recently obtained CE-IVD certification, allowing it to sell its newly registered solution in 27 countries of the European Union as well as in Iceland, Norway and Liechtenstein.
Under the agreement, Forlab will be responsible for market penetration, sales support, and product promotion in the BeNeLux region. Minimum purchase values for the Genomtec®ID analyzers and reaction cards will be reviewed on an annual basis.
ForLab SA specializes in importing and distributing clinical diagnostic products and laboratory equipment and reagents from around the world to Belgium, the Netherlands and Luxembourg. The company was founded in 1982 and is headquartered in Brussels. The Contractor’s customers are primarily academic laboratories and hospitals as well as smaller medical and general entities such as universities, institutes, government laboratories, contract research organizations, pharmaceutical and biotechnology companies.
– I am delighted with the market interest in our breakthrough solution and the addition of ForLab to our distribution family. They are a very valuable partner with extensive contacts in Belgium, the Netherlands and Luxembourg which will help us get early adopters in the European marketplace. Obtaining CE-IVD certification will be helpful in securing more commercial partners in additional countries, which we look forward to – said Charudutt Shah, Chief Business Officer in Genomtec.
On June 8, 2022, Genomtec announced obtaining the CE-IVD mark for its flagship solution, the Genomtec®ID Respiratory Panel 5-Plex (RP5-PLEX). It is the only diagnostic panel of its kind to simultaneously test for the presence of up to 5 viruses and bacteria in the same test available in Europe. The Genomtec®ID RP5-PLEX panel detects Influenza A and B viruses, RSV (Respiratory Syncytial Virus), SARS-CoV-2 and the atypical bacteria Mycoplasma pneumoniae and Chlamydophila pneumoniae. The Genomtec®ID analyzer, into which a reaction card (panel) is inserted along with a patient sample for genetic testing, is one of the smallest portable genetic testing instrument in the world.